Biomagnetic Methods: Technologies Applied to Pharmaceutical Research

ABSTRACTBiomagnetic methods have been designed for a wide range of applications. Recently, such methods have been proposed as alternatives to scintigraphy for evaluating of a number of pharmaceutical processes in vitro as well as under the influence of gastrointestinal physiological parameters. In this review, physical characterization as well as the most recent applications of Superconducting Quantum Interference Device (SQUID), Anisotropic Magnetoresistive (AMR) and AC Biosusceptometry (ACB) in the pharmaceutical research will be explored. Moreover, their current status and how these technologies can be employed to improve the knowledge about the impact of gastrointestinal physiology on drug delivery in association with pharmacokinetic outcomes, termed pharmacomagnetography, will be presented.

[1]  N. F. Kushchevskaya.  Use of ferromagnetic particles in medicine , 1997 .

[2]  S. Swithenby.  SQUIDS and their applications in the measurement of weak magnetic fields , 1980 .

[3]  O. Baffa,et al.  Influence of compression forces on tablets disintegration by AC Biosusceptometry. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  J. Dressman,et al.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. , 1997, Journal of pharmaceutical sciences.

[5]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[6]  O. Baffa,et al.  Magnetic images of the disintegration process of tablets in the human stomach by ac biosusceptometry , 2005, Physics in medicine and biology.

[7]  Romano Lapasin,et al.  Understanding Drug Release and Absorption Mechanisms: A Physical and Mathematical Approach , 2006 .

[8]  Gordon L Amidon,et al.  The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone. , 2010, Journal of pharmaceutical sciences.

[9]  Nicola Ward.  The Impact of Intestinal Failure on Oral Drug Absorption: A Review , 2010, Journal of Gastrointestinal Surgery.

[10]  W. Hauck,et al.  Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies , 1996, Clinical pharmacology and therapeutics.

[11]  J. Dressman,et al.  Estimating drug solubility in the gastrointestinal tract. , 2007, Advanced drug delivery reviews.

[12]  I. Wilding,et al.  Variation in Gastrointestinal Transit of Pharmaceutical Dosage Forms in Healthy Subjects , 1991, Pharmaceutical Research.

[13]  W. Chey,et al.  Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects , 2007, Alimentary pharmacology & therapeutics.

[14]  Dhirendra Bahadur,et al.  Biomaterials and magnetism , 2003 .

[15]  A. Peer,et al.  Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability , 2008, Pharmaceutical Research.

[16]  A. Basit,et al.  Gut instincts: explorations in intestinal physiology and drug delivery. , 2008, International journal of pharmaceutics.

[17]  O. Baffa,et al.  Analysis and development of AC biosusceptometer for orocaecal transit time measurements , 1995, Medical and Biological Engineering and Computing.

[18]  O. Baffa,et al.  Enteric Coated Magnetic HPMC Capsules Evaluated in Human Gastrointestinal Tract by AC Biosusceptometry , 2006, Pharmaceutical Research.

[19]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[20]  J. Miranda,et al.  Pharmaceutical applications of AC biosusceptometry. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  M. Camilleri.  Integrated upper gastrointestinal response to food intake. , 2006, Gastroenterology.

[22]  G. Digenis,et al.  Gamma scintigraphy: an evolving technology in pharmaceutical formulation development-Part 1 , 1998 .

[23]  Hans Lennernäs,et al.  Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. , 2009, Molecular pharmaceutics.

[24]  R. Löbenberg,et al.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards , 2000 .

[25]  M. Turkoğlu,et al.  Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers. , 2009, International journal of pharmaceutics.

[26]  V. Porta,et al.  Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers. , 2010, Clinical therapeutics.

[27]  O. Baffa,et al.  Disintegration of magnetic tablets in human stomach evaluated by alternate current biosusceptometry. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  S. Tumański,et al.  The permalloy magnetoresistive sensors-properties and applications , 1986 .

[29]  L. Groop,et al.  HYPERGLYCAEMIA AND ABSORPTION OF SULPHONYLUREA DRUGS , 1989, The Lancet.

[30]  S. Davis,et al.  Formulation strategies for absorption windows. , 2005, Drug discovery today.

[31]  C. Peloquin,et al.  Malabsorption of antimycobacterial medications. , 1993, The New England journal of medicine.

[32]  J. Dressman,et al.  Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women , 1993, Pharmaceutical Research.

[33]  Thomas J. Vidmar,et al.  Predicting Drug Absorption: How Nature Made It a Difficult Problem , 2002, Journal of Pharmacology and Experimental Therapeutics.

[34]  John Clarke,et al.  Superconducting quantum interference devices: State of the art and applications , 2003, Proceedings of the IEEE.

[35]  M. Gibaldi.  Biopharmaceutics and clinical pharmacokinetics , 1977 .

[36]  H. Junginger,et al.  Macromolecules as safe penetration enhancers for hydrophilic drugs—a fiction? , 1998 .

[37]  L. Trahms,et al.  Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[38]  Gordon L Amidon,et al.  A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.

[39]  Kazutaka Higaki,et al.  Gastrointestinal transit and drug absorption. , 2000, Biological & pharmaceutical bulletin.

[40]  A. Basit,et al.  Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. , 2010, International journal of pharmaceutics.

[41]  Juergen Siepmann,et al.  Drug delivery to the upper small intestine window using gastroretentive technologies. , 2006, Current opinion in pharmacology.

[42]  Clive G. Wilson,et al.  Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  I. Wilding,et al.  The role of γ-scintigraphy in oral drug delivery , 1991 .

[44]  J. Barone.  Domperidone: A Peripherally Acting Dopamine2-Receptor Antagonist , 1999, The Annals of pharmacotherapy.

[45]  M. Horowitz,et al.  Pharmacokinetic Considerations in Gastrointestinal Motor Disorders , 1995, Clinical pharmacokinetics.

[46]  M D Donovan,et al.  Drug transfer through mucus. , 2001, Advanced drug delivery reviews.

[47]  T. Murakami,et al.  Expression and function of efflux drug transporters in the intestine. , 2006, Pharmacology & therapeutics.

[48]  Siddharth Singh,et al.  Day‐to‐day reproducibility of prolonged ambulatory colonic manometry in healthy subjects , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[49]  G. Digenis,et al.  Gamma scintigraphy: an evolving technology in pharmaceutical formulation development—Part 2 , 1998 .

[50]  Mayur M. Patel,et al.  Therapeutic opportunities in colon-specific drug-delivery systems. , 2007, Critical reviews in therapeutic drug carrier systems.

[51]  L Trahms,et al.  Magnetic marker monitoring of disintegrating capsules. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[52]  H Lennernäs,et al.  Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.

[53]  W. Jia,et al.  Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system. , 2010, Chemical & pharmaceutical bulletin.

[54]  P. Nava,et al.  Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation. , 2005, Advanced drug delivery reviews.

[55]  Sanyog Jain,et al.  Pharmacoscintigraphy: a blazing trail for the evaluation of new drugs and delivery systems. , 2009, Critical reviews in therapeutic drug carrier systems.

[56]  Hans Lennernäs,et al.  Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.

[57]  H Lennernäs,et al.  Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag. , 1999, Acta physiologica Scandinavica.

[58]  Vinod Nair,et al.  Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. , 2004, Current drug metabolism.

[59]  E. Doelker,et al.  Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery , 1996 .

[60]  M. Levina,et al.  The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. , 2004, Journal of pharmaceutical sciences.

[61]  J. Miranda,et al.  The ACB technique: a biomagentic tool for monitoring gastrointestinal contraction directly from smooth muscle in dogs , 2010, Physiological measurement.

[62]  Leslie Z Benet,et al.  The drug transporter-metabolism alliance: uncovering and defining the interplay. , 2009, Molecular pharmaceutics.

[63]  L. Trahms,et al.  Oesophageal transport of solid dosage forms depends on body position, swallowing volume and pharyngeal propulsion velocity , 2004, Neurogastroenterology and Motility.

[64]  S. Chandran,et al.  Multiparticulate formulation approach to colon specific drug delivery: current perspectives. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[65]  E. Quigley,et al.  Gastric and small intestinal motility in health and disease. , 1996, Gastroenterology clinics of North America.

[66]  H. Lennernäs,et al.  Oral Drug Absorption: Prediction and Assessment , 2000 .

[67]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[68]  J. Miranda,et al.  AC biosusceptometry technique to evaluate the gastrointestinal transit of pellets under influence of prandial state. , 2010, Journal of pharmaceutical sciences.

[69]  V. Porta,et al.  Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers. , 2009, International journal of pharmaceutics.

[70]  T. Sagara,et al.  Magnetoresistive Sensors , 1993, IEEE Translation Journal on Magnetics in Japan.

[71]  Y Zhang,et al.  Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[72]  O. Baffa,et al.  AC biosusceptometry in the study of drug delivery. , 2005, Advanced drug delivery reviews.

[73]  Clive G. Wilson,et al.  Gastrointestinal Transit and Drug Absorption , 2005 .

[74]  W Weitschies,et al.  Determination of the disintegration behavior of magnetically marked tablets. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  M E Bellemann,et al.  A novel method for real-time magnetic marker monitoring in the gastrointestinal tract , 2000, Physics in medicine and biology.

[76]  V. Porta,et al.  Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: an open-label, randomized, single-dose, two-way crossover study. , 2008, Clinical therapeutics.

[77]  Hans Lennernäs,et al.  The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension , 2005, The Journal of pharmacy and pharmacology.

[78]  Lutz Trahms,et al.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.

[79]  D. Young,et al.  Pharmaceutical Product Development : In Vitro-In Vivo Correlation , 2007 .

[80]  Matthew Roberts,et al.  The use of hypromellose in oral drug delivery , 2005, The Journal of pharmacy and pharmacology.

[81]  M. Horowitz,et al.  Gastric emptying in diabetes: clinical significance and treatment , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[82]  Alessio Fasano,et al.  Tight junction modulation and its relationship to drug delivery. , 2006, Advanced drug delivery reviews.

[83]  Leslie Z Benet,et al.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. , 2008, Advanced drug delivery reviews.

[84]  Alex I. Braginski,et al.  Biomagnetism using SQUIDs: status and perspectives , 2006 .

[85]  G. Corazza,et al.  Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics , 2004, Alimentary pharmacology & therapeutics.

[86]  Matthias E Bellemann,et al.  A novel magnetic method for examination of bowel motility. , 2005, Medical physics.

[87]  W. Ritschel,et al.  Gastrointestinal parameters that influence oral medications. , 1993, Journal of pharmaceutical sciences.

[88]  Vittorio Pizzella,et al.  SQUID systems for biomagnetic imaging , 2001 .

[89]  Ho-Chul Shin,et al.  Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model , 2006, Pharmaceutical Research.

[90]  Arvind K. Bansal,et al.  A Means to Address Regional Variability in Intestinal Drug Absorption , 2003 .

[91]  Lutz Trahms,et al.  Impact of the intragastric location of extended release tablets on food interactions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[92]  H. Lennernäs,et al.  Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms , 1997, The Journal of pharmacy and pharmacology.

[93]  A. Urtti,et al.  Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[94]  Mei-ling Chen,et al.  Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. , 2008, Advanced drug delivery reviews.

[95]  R. C. Evangelista,et al.  Chitosan-pectin multiparticulate systems associated with enteric polymers for colonic drug delivery , 2010 .

[96]  R. Panchagnula,et al.  Extrusion and spheronization in the development of oral controlled-release dosage forms. , 1999, Pharmaceutical science & technology today.

[97]  H. Mönnikes,et al.  Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[98]  P. Hellström,et al.  The physiology of gastric emptying. , 2006, Best practice & research. Clinical anaesthesiology.

[99]  I. Legen,et al.  Comparison of different intestinal epithelia as models for absorption enhancement studies. , 2005, International journal of pharmaceutics.

[100]  W. Weitschies,et al.  Mechanistic Modeling of a Magnetic Marker Monitoring Study Linking Gastrointestinal Tablet Transit, In Vivo Drug Release, and Pharmacokinetics , 2009, Clinical pharmacology and therapeutics.

[101]  J. Miranda,et al.  Electrical and mechanical effects of hyoscine butylbromide on the human stomach: a non-invasive approach , 2009, Physiological measurement.

[102]  A. Megens,et al.  Loperamide. Survey of studies on mechanism of its antidiarrheal activity. , 1993, Digestive diseases and sciences.

[103]  J. Krämer,et al.  Biopharmaceutical aspects of multiparticulates , 1994 .

[104]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[105]  Roland Bodmeier,et al.  Tableting of coated pellets , 1997 .

[106]  O. Baffa,et al.  Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[107]  Brahma N. Singh.  Effects of Food on Clinical Pharmacokinetics , 1999, Clinical pharmacokinetics.

[108]  F. Ahmad,et al.  Colonic drug delivery: an updated review. , 2003, AAPS pharmSci.